Punit Dhillon insider trades: Skye Bioscience (SKYE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Punit reports to the SEC
and 2 more companies
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | SKYE | ↓ Sell | 82,910 | $4.99 | $414K | Direct | Nov 19, 2024 (1d) |
| Aug 29, 2023 | SKYE | ↑ Buy | 881,000 | $0.02 | $16K | Direct | Aug 29, 2023 (0d) |
| Aug 7, 2020 | EMBI | ↑ Buy | 1,000,000 | $100000.00 | $100.00B | Direct | Aug 11, 2020 (4d) |
| Jul 5, 2018 | ONCS | ↓ Sell | 220,440 | $1.38 | $305K | Direct | Jul 6, 2018 (1d) |
| Feb 6, 2018 | ONCS | ↑ Buy | 3,000 | $0.88 | $3K | By the Dhillon Living Trust dated May 24 | Feb 6, 2018 (0d) |
| Jul 31, 2017 | ONCS | ↑ Buy | 3,000 | $0.88 | $3K | By the Dhillon Living Trust dated May 24 | Aug 2, 2017 (2d) |
| Jan 31, 2017 | ONCS | ↑ Buy | 3,000 | $0.99 | $3K | By the Dhillon Living Trust dated May 24 | Feb 2, 2017 (2d) |
| Jul 31, 2016 | ONCS | ↑ Buy | 3,000 | $1.44 | $4K | By the Dhillon Living Trust dated May 24 | Aug 5, 2016 (5d) |
| Oct 16, 2015 | ONCS | ↑ Buy | 9,900 | $4.25 | $42K | Direct | Oct 19, 2015 (3d) |
| Jun 10, 2015 | ONCS | ↑ Buy | 2,500 | $6.74 | $17K | Direct | Jun 11, 2015 (1d) |
| Mar 19, 2014 | ONCS | ↑ Buy | 50,000 | $0.80 | $40K | Direct | Mar 20, 2014 (1d) |
| Mar 1, 2011 | ONCS.D | ↑ Buy | 3,642,000 | $0.00 | $1K | Direct | Mar 24, 2011 (23d) |
| Mar 1, 2011 | ONCS.D | ↑ Buy | 752,000 | $0.00 | $226 | Indirect | Mar 24, 2011 (23d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SKYE insiders
Open-market trades in the last 12 months
About Punit Dhillon's insider trades
Punit Dhillon is Chief Executive Officer at Skye Bioscience (SKYE). Since Mar 1, 2011, Punit has reported 11 open-market purchases worth $100.00B and 2 sales worth $719K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (31 filings), shares returned to the company (2 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SKYE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.